To determine whether RBM436-507 represents a target of neutralizing antibodies in natural conditions, we first carried out an extensive ELISA analysis of sera from both COVID-19 patients and immunized mice, and second, we compared the ACE2-RBD binding neutralization by antibodies to the whole RBD and to RBM436-507. The gene discussed is ACE2; the disease is COVID-19.